Skip to main content

Events & Presentations

February 27-28, 2025

Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX

Building on the first Founders Longevity Forum held in June in London, at which Dr. Slawin brought our company out of five years of “stealth mode” to present our company…

March 14, 2025 | Toulouse, FR

Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX.

“Novel Senolytic Peptides Alleviate Sarcopenia And Frailty In Naturally Aged Mice By Targeting Senescent Cells” International Conference of Frailty and Sarcopenia Research 2025 – oral communication on the plenary session…

14 November 2024 | 12:30 PM GMT/7:30 AM EST | Online

Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX

In this longevity-investing focused webinar, Dr. Slawin will be presenting Eos SENOLYTIX, giving a sneak preview of the groundbreaking data he will be presenting in March at the International Conference…

June 10-11, 2024 | London, England

Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX

At the Founders Longevity Forum in London on June 10-11, 2024, Dr. Slawin brought our company out of five years of “stealth mode” to present our company publicly for the…